The interpretation of CA-125 assay results, with particular focus on ovarian cancer patients undergoing therapy has been extensively reported.[18,19] CA-125 tests and imaging results are routinely used for ovarian cancer patients who are in clinical remission.[20] In this case, the CA-125 quickly reverted to the normal value after treatment with the new regimen. This evidence concerns the gene MUC16 and ovarian cancer.